Modernising Medical Microbiology
Modernising Medical Microbiology is a research group aiming to transform how we analyse and treat infections, to improve patient care.
We aim to:
- Modernise the way we analyse infections, bringing cutting-edge scientific techniques to clinical care.
- Transform they way we study the treatment of patients with infections, using large databases of hospital electronic information, to identify trends in how infections are behaving, and ways patient care can be improved.
- Use techniques such as DNA analysis of bacteria and viruses to better understand how infections spread, how to treat them, and how to prevent them in the future.
- Study how bacteria become resistant to antibiotics, and more difficult to treat, and how to prevent this.
Modernising Medical Microbiology studies a number of infections, in particular, Mycobacterium tuberculosis (TB), - the Enterobacterales family (Escherichia coli, Klebsiella species and others) and Clostridium difficile (C. diff). You can learn more about these bacteria here
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
Bešević J. et al, (2023), Journal of epidemiology and community health
Deep learning and single-cell phenotyping for rapid antimicrobial susceptibility detection in Escherichia coli.
Zagajewski A. et al, (2023), Communications biology, 6
Swab pooling enables rapid expansion of high-throughput capacity for SARS-CoV-2 community testing.
Fagg J. et al, (2023), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 167
The Modernising Medical Microbiology Research Group has many active research projects.
You can learn more about the projects here.
If you are interested in being a part of our public engagement team, please get in contact!
Pathogens and viruses
What Pathogens and Viruses do the MMM team research?